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Abstract
Background: Several studies have shown that activation of the renin-angiotensin system may lead to hypertension, a major
risk factor for the development of chronic kidney disease (CKD). The existing hypertension-induced CDK mouse models are
quite fast and consequently away from the human pathology. Thus, there is an urgent need for a mouse model that can be
used to delineate the pathogenic process leading to progressive renal disease. The objective of this study was dual: to
investigate whether mice overexpressing renin could mimic the kinetics and the physiopathological characteristics of
hypertension-induced renal disease and to identify cellular and/or molecular events characterizing the different steps of the
progression of CKD.
Methodology/Principal Findings: We used a novel transgenic strain, the RenTg mice harboring a genetically clamped renin
transgene. At 3 months, heterozygous mice are hypertensive and slightly albuminuric. The expression of adhesion markers
such as vascular cell adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 are increased in the renal
vasculature indicating initiation of endothelial dysfunction. At 5 months, perivascular and periglomerular infiltrations of
macrophages are observed. These early renal vascular events are followed at 8 months by leukocyte invasion, decreased
expression of nephrin, increased expression of KIM-1, a typical protein of tubular cell stress, and of several pro-fibrotic
agents of the TGFb family. At 12 months, mice display characteristic structural alterations of hypertensive renal disease such
as glomerular ischemia, glomerulo- and nephroangio-sclerosis, mesangial expansion and tubular dilation.
Conclusions/Significance: The RenTg strain develops CKD progressively. In this model, endothelial dysfunction is an early
event preceding the structural and fibrotic alterations which ultimately lead to the development of CKD. This model can
provide new insights into the mechanisms of chronic renal failure and help to identify new targets for arresting and/or
reversing the development of the disease.
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Introduction
Several studies estimate that the number of patients affected by
CKD is in sharp rise in western countries [1]. Decline of renal
function can be slowed down by therapies targeting the renin
angiotensin system (RAS) but they are partially effective [2].
Therefore, dialysis or transplantation are the only available
options allowing the survival for the majority of patients whom
number requiring such treatment is steadily increasing worldwide.
Thus, proposing more effective treatments for arresting or even
better reversing the progression of CKD is one of the major
challenges of public health today.
CKD can be promoted by a variety of mechanisms including
hypertension which may affect any of the kidney structures by
promoting development of chronic inflammation leading to
fibrosis and progressive decline of renal function [3]. One of the
main objectives of our research group over the last years has been
the identifications of molecular mechanisms responsible for the
development of renal fibrosis. For this purpose, we use a multi-
target strategy based on experimental models of nephropathies in
rodents to study mediators of inflammation, progression, stabili-
zation or regression of renal lesions [4–8]. Even if these
experimental models had provided new insights towards the
progression and regression of CKD, a relative limitation would
have been the fact that renal disease was induced in young animals
for a rather short period of time. Consequently in these models,
animals did not suffer for a long period of time from a chronic
disease such as hypertension or diabetes as it is usually the case in
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Figure 1. RenTg mice are hypertensive and develop chronic kidney disease progressively with the age. Systolic blood pressure was
highly increased in RenTg mice since the age of 3 months as compared to aged matched WT controls (A). Urinary excretion of albumin progressively
increased with age to reach at 12 months highly elevated values in RenTg mice (B) whereas GFR significantly decreased (C). In accordance, the
percentage of sclerotic glomeruli progressively increased in RenTg mice compared to WT mice (D). Representative examples of renal cortical slices
after Masson’s Trichrome histology (E–I). Renal cortex of WT (E) as well as 3 month-old RenTg appeared normal (F); inflammatory lesions and renal
fibrosis were evident at 5 (G), and 8 (H) months respectively in RenTg mice. Renal cortical tissue of 12 month old RenTg mice displayed several of the
characteristics of hypertension-associated renal disease such as peri- vascular and glomerular inflammation, glomerulosclerosis, fibrinoid-like deposits
within renal vessels, glomerular ischemia and tubular dilatation (I). Values are means6 SEM; n = 8 and 9 for wild type and RenTg mice, respectively for
each time point; *P,0,05 or **P,0,01 vs WT. Magnification of the microphotographs: X200.
doi:10.1371/journal.pone.0052362.g001
Figure 2. Alterations of endothelial function markers in RenTg mice. Immunohistochemistry on renal cortical cryosections showed a marked
increase of the PECAM-1 (CD31) expression in the 3 month old RenTg mice as compared to the control tissues (A). Quantitative RT-PCR analysis
showed a progressive increase of VCAM-1 in the RenTg mice (B). Note that the ET-1 mRNA expression is up-regulated at the later stages of the renal
disease (C). Values are presented as fold increase as compared to the age matched WT mice and are means 6 SEM; n = 8 and 9 for wild type and
RenTg mice, respectively for each time point; *P,0,05 or **P,0,01 vs WT. Magnification of the microphotographs: X200.
doi:10.1371/journal.pone.0052362.g002
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humans. Thus, it can be argued that the mechanisms of
progression were very fast, diverging from the slow progression
of CKD in humans and inversely that the demonstrated efficiency
of therapy was mainly due to the young age of animals.
For this purpose we used the RenTg mouse, a novel
hypertensive transgenic model that overexpresses renin at high
and constant levels after genetic clamping hypothesizing that it
will progress with a slower rate towards CKD. In a recently
published first study, we addressed the issue of whether aged
mice, suffering for a long period from hypertension, can be
efficiently treated using RAS antagonists [9]. Indeed, we found
that the decline of renal function, as well as alterations in the
expression of proteins involved in the integrity and the function
of the kidney, were partially reversible when 13 month old
animals were treated by an AT1 receptor antagonist [9]. In the
present study, we investigated the kinetics and the physiopath-
ological events at the cellular and molecular level that delineate
the pathogenic process leading to progressive development of
renal disease associated to the activation of RAS. We propose
that the RenTg strain is a useful model to study the different
phases of progression and to identify the pathological pathways
involved in the evolution of CKD.
Results
RenTg mice Develop Hypertension-induced Progressive
Renal Disease
RenTg mice were generated as already described [10]. We have
recently shown that these mice display high blood pressure
associated to an advanced phase of renal disease (12 month old
mice). To study sequential events leading to progressive CKD we
measured arterial blood pressure and examined alterations of
kidney structure and function in RenTg mice and littermates from
3 to 11 month old animals. As expected, RenTg mice displayed
elevated systolic blood pressure from 3 month old (15367 mmHg
compared to 12062 for the WT age matched animals, p,0.05,
Fig. 1A). Proteinuria was slightly augmented at 3 months and
progressively increased with age to reach at 11 months highly
elevated values as compared to the WT control animals
(5.1560.09 g/mol and 130620 g/mol of creatinine for WT and
RenTg mice respectively, p,0.01, Fig. 1B). Decline of renal
function was also confirmed by glomerular filtration rate (GFR)
measurements and glomerulosclerosis evaluation. RenTg mice
showed a progressive decrease of GFR (Fig. 1C). In accordance,
the percentage of sclerotic glomeruli was significantly increased at
8 months in RenTg mice (Fig. 1D). As illustrated by Masson’s
trichrome, at the early stages of the disease (3 month old) renal
morphology appeared to be normal (Fig. 1F) whereas moderate
infiltrate was detected in 5 month-old RenTg mice (Fig. 1G).
Histological examination at 8 months showed marked tubular
dilatation (Fig. 1H). Finally, kidneys of 12 month-old RenTg
displayed well-established lesions in all renal compartments such as
peri- vascular and glomerular inflammation, glomerulosclerosis,
fibrinoid-like deposits within renal vessels, glomerular ischemia
and tubular dilatation (Fig. 1I).
Altered Expression of Cell Adhesion Markers in RenTg
mice
Endothelial dysfunction is considered as the starting point of
injury in various inflammatory diseases and can be initiated in part
by alterations of cell adhesion markers (CAMs) expression.
Immunostaining in the renal cortex of 3 month-old RenTg mice
revealed a pronounced upregulation of the endothelial marker
CD31/PECAM-1 (platelet endothelial cell adhesion molecule-1)
in the peritubular microcirculation as well as in the glomerular and
vascular endothelium (Fig. 2A). In addition, mRNA levels for
vascular adhesion molecule-1 (VCAM-1) which is essential for the
recruitment of inflammatory cells were continuously increased
from 3 months (Fig. 2B) as well as those of the intercellular cell
adhesion molecule-1 (ICAM-1, data not shown). mRNA for
endothelin-1 (ET-1) was upregulated only during the later time
points of the disease (Fig. 2C). These data showed that the
expression of several CAMs was altered at the early stages of the
disease, indicating that endothelial dysfunction may play a leading
role in the development of CKD.
Inflammatory Cell Infiltration in RenTg mice
Upregulation of CAMs initiates adhesion of inflammatory cells
in the damaged tissues. Thus, the next step was to study
inflammation in the injured kidneys of RenTg mice during the
progression of chronic kidney disease. Immunostaining for CD68
revealed some macrophage infiltration in cortical slides of the 5
month-old in RenTg mice (Fig. 3A). The infiltrate was much more
significant at the latter stages of the disease. In addition,
lymphocyte infiltration was detected at a later age (7 months)
and became more pronounced in 12 month-old RenTg mice as
indicated by CD3 immunostaining (Fig. 3B). CD68 and CD3
immunostainings were negligible for the WT animals at each time
point (data not shown). In conclusion, the inflammatory process
appeared after alteration of CAMs expression during progression
of CKD in RenTg mice.
Progression of Renal Fibrosis in RenTg mice
Matrix remodelling commonly follows inflammatory response
and is characterized by changes in the TGFb/BMP balance.
Consequently, we measured gene expressions of pro- and anti-
fibrotic genes of the TGFb/BMP superfamily at different phases of
CKD progression. As shown in Figure 4A mRNA expression for
TGFb1 was upregulated since 8 months and peaked high levels at
12 months. The renal expression of several members of the BMPs
family (BMP-2, BMP-4, BMP-6, BMP-7) which are known to
antagonize TGFb actions did not change throughout the
development of CKD in all tested ages (data not shown). However,
the expression of BMPR2, a BMP receptor, was down regulated
from the early stages of the disease (Fig. 4B). Interestingly, the
expression of agents acting as endogenous inhibitors of BMPs,
such as uterine sensitization-associated gene-1 (USAG-1), was
markedly upregulated in the renal cortex of the RenTg mice at the
latest stages of renal disease (Fig. 4C), whereas Id-1 mRNA
expression, a BMP-pathway target gene, was several folds
decreased (Fig. 4D). To examine whether overexpression of renin
could compromise cardiac function we also measured some typical
markers of cardiac hypertrophy such as brain natriuretic peptide
(BNP) and the ratio of b/a myosine heavy chain (MHC) (Fig. 4E
Figure 3. Inflammatory cell infiltration during the progression of CKD in RenTg mice. Representative examples of renal cortical sections
for macrophages (CD68) and lymphocytes (CD3) immunostaining, respectively. Note that macrophage infiltration was first detected since the age of 5
months in the renal cortex of RenTg mice (A), whereas a positive staining for lymphocytes was observed at 7 month-old RenTg mice (B).
Magnification of the microphotographs: X200.
doi:10.1371/journal.pone.0052362.g003
RenTg Mice and Chronic Kidney Disease
PLOS ONE | www.plosone.org 5 December 2012 | Volume 7 | Issue 12 | e52362
RenTg Mice and Chronic Kidney Disease
PLOS ONE | www.plosone.org 6 December 2012 | Volume 7 | Issue 12 | e52362
and 4F respectively). As expected, mRNA expression of these two
markers was highly increased indicating that RenTg mice develop
cardiac hypertrophy with age. Similar results were observed by
estimating the heart weight reported to the body weight of the
animals (Fig. 4G).
In accordance with real-time PCR experiments, Sirius red
staining showed that collagen deposition was progressively
increased in the renal cortex (Fig. 5A, 5B and 5C) as well as in
cardiac tissues (Fig. 5D, 5E and 5F) of injured animals from the
age of 5 months. These results indicate that the equilibrium of
TGFb/BMP balance was shifted towards the pro-fibrotic agents of
this family after the initial endothelial and inflammatory events.
Altered Expression of Proteins Characterizing the
Integrity and/or Phenotype of Podocytes and Proximal
Tubular Cells
To provide cellular assessment of the previous described
modifications we studied the expression of two markers essential
for the normal structure and function of the kidney. Figure 6A
shows that expression of the nephrin mRNA, a protein essential
for the normal structure of podocytes, started to decrease in
RenTg mice relatively late (after 8 months). Similarly, the
expression of kidney injury molecule-1 (KIM-1), an indicator of
renal tubular damage, was two-fold upregulated at 8 months
compared to their respective control animals (Fig. 6B). Interest-
ingly, E-cadherin, a tubular marker of normal epithelial phenotype
was decreased only at the latest stages of the renal disease (Fig. 6C).
These data suggest that the phenotypic alterations in podocytes
occur during the intermediate to advanced stages of renal disease
and are associated to tubular stress signals while the loss of the
proximal tubule phenotype is a rather late event in this model of
CKD.
In conclusion, our data indicate that the development of CKD
in RenTg mice results from a continuous decline of renal function
associated with sequential events such as endothelial dysfunction,
inflammation and alterations in the TGFb/BMP equilibrium, all
leading to structural changes within all renal compartments.
Discussion
During the last years, the incidence of CKD is in sharp rise in
western countries, mainly because of population ageing, improved
survival from cardiovascular diseases and epidemic spreading of
type-2 diabetes. Thus, the prevention, arrest and/reversal of
decline of renal function are major public health priorities as
current treatments are only partially effective. A better under-
standing of the mechanisms involved in this pathology is essential
to develop more effective and specific therapies. CKD may be
caused by diseases that affect any of the renal structures, including
vessels, glomeruli and the tubule-interstitial compartment. The
damage can be induced by various pathologies; the most
prominent are hypertension and diabetes [11–12]. These processes
are linked by their ability to promote inflammatory reactions and
tissue scaring that destroys the structure and the function of
individual nephrons.
Persistent RAS activation plays a major role in renal disease
progression [13]. Indeed, regression of proteinuria and renal
fibrosis by blocking the RAS action has been reported in some
experimental models of CKD in rodents, such as chronic nitric
oxide deficiency, infusion of AngII by osmotic minipumps,
nephrectomy or puromycin aminonucleoside [6,14–16]. However,
a potential limitation of these studies is that the disease was
induced in young animals not suffering for a long period from a
chronic disease like hypertension or diabetes. Thus, all these
models of kidney injury are very fast with kinetics deviating a lot
from the development of CKD. Another complication in these
animal models is the uncontrolled homeostatic feedback that
occurs subsequent to genetic or experimental manipulations. In
addition, in some cases therapy was induced before reaching high
levels of proteinuria and a significant level of renal structural
damage. To address these issues we used a novel model of Ang II-
induced renal disease which we hypothesized could mimic closer
the kinetics and the physiopathological characteristics of hyper-
tension-associated renal disease. This strain, also known as
RenTgKC mice, is viable, fertile and suitable thus for studying
sequential events leading to progressive development of renal
disease. In addition, by expressing the transgene in the liver,
driven by a liver-specific promoter/enhancer, the ectopically
produced active renin is completely freed from normal renal
homeostatic adjustments, and is therefore clamped. Furthermore,
because the transgene is of mouse origin, the resulting high
circulating active renin can interacts with other components of the
mouse RAS leading to a severe Ang II-mediated hypertension and
to kidney damage [10]. Of note, we preferred to use the
RenTgKC model instead of the RenTgMK one, another variant
of the RenTg mice, because of the lower expression of the renin
transgene RenTgKC mice don’t die rapidly from heart failure and
they can live long enough to develop renal disease.
In models of hypertension-induced renal disease, such as nitric
oxide deficiency or infusion of AngII by osmotic minipumps, there
is a progressive increase of the blood pressure during the first 3–5
days. Thereafter blood pressure is stabilized at the same high level
for weeks. In contrast, renal structure is not altered during the first
weeks. Depending on the species and the genetic background the
first visible alterations appear after few or several weeks and the
renal structure continues to deteriorate with time, although blood
pressure is unchanged. Rentg mice mimic to a slower, thus more
progressive, rate the above-mentioned models. Blood pressure is
increasing gradually during the first weeks of life, and then is
stabilized and then the structural and functional alterations appear
and continue to be deteriorated with time. Similar observations
are also described in spontaneously hypertensive rats.
Among the first major cellular events observed in RenTg mice
was a significant increase of the CAM expression. It is generally
believed that the vascular endothelium serves as a barrier by
providing a non adherent surface to inflammatory cells. However,
upon Ang II stimulation, endothelium becomes dysfunctional as
the expression of CAMs and chemokines, such as VCAM-1,
ICAM-1 and MCP1, is upregulated thus promoting infiltration of
inflammatory cells within the damaged tissue [17–19]. Therefore,
Figure 4. Changes in the TGFb/BMP balance and cardiac hypertrophy during the progression of CKD in RenTg mice. Quantitative RT-
PCR analysis of TGF-b1 (A), BMPR2 (B), USAG-1 (C) and Id-1 (D) in the renal cortex of wild type and RenTg mice. Note that the expression of BMPR2 has
been decreased since 3 months in RenTg mice while at the expressions of TGF-b1 and USAG-1, an endogenous inhibitor of BMPs, were highly
increased from 8 months in injured tissues. Significant down regulation of Id-1 mRNA expression, a BMP7 target gene is also detected after 8 months.
In addition, qPCR analysis of typical markers of cardiac hypertrophy, such as BNP (E) and b-MHC/a-MHC ratio (F), as well as measurements of the heart
weight (H), confirmed that RenTg mice developed cardiac hypertrophy with age. Values are presented as fold increase or decrease as compared to
the age matched WT mice and are mean 6 SEM; n= 8 and 9 for wild type and RenTg mice, respectively for each time point; *P,0,05 or **P,0,01 vs
WT.
doi:10.1371/journal.pone.0052362.g004
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an impairment of the resident endothelium may contribute to the
initiation of chronic renal injury. In addition, an upregulation of
the ET-1 production, which is absent in the normal kidney, was
observed at the later stages of the disease in RenTg animals. We
have previously demonstrated that ET-1 is an important mediator
of the fibrogenic action of Ang II which can activates its synthesis
[20]. Of note, at 8 months RenTg mice presented increased
expression of ET-1 which corroborated with installation of
interstitial fibrosis.
Changes in the TGFb/BMP balance control the regulation and
relative expression between pro and anti-fibrotic members and can
play a crucial role in the progression of CKD. It has been recently
shown that exogenous administration of BMP7 reversed renal
fibrosis in some animal models of CKD [21–22]. Although we
didn’t observe a significant decrease in its endogenous levels, we
found an early decrease of the expression of BMP receptors. As the
disease progressed, TGFb and its cofactors were upregulated
together with a parallel increase in the expressions of endogenous
inhibitors of BMPs. These altered expressions in the pro-fibrotic
members of the TGFb superfamily were associated to the
development of fibrotic lesions. These results are in agreement
with previous observations showing that overexpression of USAG-
1 accompanied renal fibrosis, whereas blockade of AT1 receptor
and reversal of renal disease was associated with the inhibition of
USAG-1 activation [9,23–24]. It appears thus, that the develop-
ment of renal fibrosis is a complex phenomenon involving several
mechanisms such as a direct fibrogenesis through activation of
TGFb accompanied with an inhibition of BMPs action either by
down-regulation of the BMP receptor and/or activation of BMPs
endogenous antagonists.
Proteinuria is a major marker of the severity of renal disease and
predicts the risk of progression [12]. Elevated proteinuria is
basically associated with the disruption of slit diaphragm and loss
of podocyte foot processes, structural alterations that used to be
considered as irreversible. We have previously shown ultrastruc-
tural modifications in the glomerular structure of 12 months old
RenTg mice [9]. In particular, podocyte foot processes disap-
peared while glomerular basement membranes displayed abnor-
mal thickness. In the present study we found that the alterations in
the expressions of proteins indicating phenotype changes in
podocytes and tubular epithelium (such as nephrin, E-cadherin,
KIM-1) are rather late events and occur well after the appearance
of the inflammatory and fibrotic lesions.
In conclusion, our data indicate that the development of CKD
in RenTg mice results from a continuous decline of renal function
associated with sequential events such as endothelial dysfunction,
inflammation and alterations in the TGFb/BMP equilibrium, all
leading to structural changes within all renal compartments. We
can therefore assume that RenTg mice can be cross-bred with
other transgenic strains to provide double transgenic animals
suffering from progressive hypertension and CKD, lacking or
over-expressing a given protein to study its implication in the
disease. Consequently, such a model may constitute a powerful
tool to study new insights on the mechanisms involved in the
progression and regression of chronic renal disease.
Materials and Methods
Animals
Experiments were performed using RenTg mice backcrossed in
the genetic background 129SV as already described [9]. These
mice express renin ectopically at a constant high level in the liver
leading to elevated mRNA (2.760.3 renin/18S versus 0 in RenTg
and WT mice respectively) and protein levels of active renin into
the blood stream [10]. Thus, RenTg mice are hypertensive as
endogenous synthesis of angiotenin II is increased. Male RenTg
and WT counterparts were sacrificed at 3, 5, 8 and 12 months. At
least 8 mice per group, and for each time point, have been used for
the experiments. Kidneys were removed, decapsulated, and the
cortex was dissected from the medulla. The cortical tissue is then
used for RNA extraction and immunohistochemistry.
All mice were kept in well-controlled animal housing facilities
and had free access to tap water and pellet food. All protocols were
performed according to the French Institutional Committee
guidelines (INSERM and the University of Pierre et Marie Curie,
Paris).
Measurement of Systolic Arterial Pressure
Systolic arterial pressure (mmHg) was measured using a tail-cuff
sphygmomanometer adapted to the mouse as described [9].
Briefly, animals were accustomed for three weeks before
measurements. Only not stressed mice that showed stable and
reproducible values of blood pressure for at least three consecutive
days were considered for the measurements. Ten measurements
from each mouse were taken at two minutes intervals then a mean
value was determined. To avoid variations due to day cycle all
blood pressure measurements were carried out between 9 and
11a.m.
Measurements of Urinary Albumin Excretion
RenTg mice and aged-matched controls were transferred in
metabolic cages with free access to food and water for 24-hour
urine collection. Measurements of microalbuminuria were per-
formed as previously reported [9]. Urinary albumin concentration
was normalized to urinary creatinine concentration, and values
were expressed as g albumin/mol creatinine.
Glomerular Filtration Rate
GFR was measured using the single bolus injection method of
FITC-inulin as previously described [25]. Briefly, RenTg mice and
their littermates (n = 5 mice per group) were injected retro-
orbitally under isoflurane anesthesia with 3.74 ml/g of body weight
5% FITC-inulin solution (Sigma-Aldrich). Blood samples were
collected every 15 minutes during 90 minutes and plasma was
isolated after centrifugation. GFR was estimated and expresses in
ml/min 6 SEM.
Renal Morphology and Evaluation of Interstitial Fibrosis
One kidney from each animal was fixed in formalin solution
(4%), embedded in paraffin after conventional processing, and
sections (3 mm thick) were stained with Masson’s trichrome for
histological evaluation, glomerulosclerosis and Sirius red for
Figure 5. Progression of renal interstitial and cardiac fibrosis in hypertension-induced CKD. Representative example of Sirius red staining
in WT (A) and RenTg (B) 12 month-old mice. Quantification by morphometric analysis of renal cortical paraffin embedded sections after Sirius Red
staining is shown in panel C. Fibrillar collagen content was progressively increased in RenTg mice after 5 months. Similar results were observed in
heart sections of WT (D) and RentTg (E) 12 month-old mice. Quantification of cardiac fibrosis is shown in panel F. Values are presented as fold increase
as compared to the age matched WT mice and are means6 SEM; n= 8 and 9 for wild type and RenTg mice, respectively for each time point; *P,0,05
vs WT.
doi:10.1371/journal.pone.0052362.g005
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Figure 6. Alterations of mRNA expression of podocyte and tubular markers during progression of CKD in RenTg mice. Quantitative
RT-PCR analysis of nephrin (A), KIM-1 (B) and E-cadherin (C) in the renal cortex of wild type and RenTg mice. Note that the expression of nephrin is
decreased since 8 months in RenTg mice while at the same age the expression of KIM-1 was highly increased. Significant differences in E-cadherin
expression were detected in the 12 month old RenTg mice. Values are presented as fold increased or decreased as compared to the age matched WT
mice and are mean6SEM; n= 8 and 9 for wild type and RenTg mice, respectively for each time point; *P,0,05 or **P,0,01 vs WT.
doi:10.1371/journal.pone.0052362.g006
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analysis of fibrillar collagen. Interstitial fibrosis was assessed semi-
quantitatively on Sirius red stained paraffin sections at magnifi-
cation of X200. Fibrosis was then quantified using computer-based
morphometric analysis software (Analysis, Olympus) that allowed
the formation of a binary image in which the stained area could be
automatically calculated as percentage of the image area. To
obtain a percentage of glomeruloscelrosis, the number of sclerotic
glomeruli were referred to the totality of glomeruli evaluated for
each mouse (mean = 90 glom/mouse). Ten fields per section that
covered nearly the whole piece of cortex were randomly selected.
Scoring was performed in blind on coded slides.
Immunohistochemistry
Immunostainings were performed on frozen fixed with acetone
for 3 min and paraffin embedded 3 mm thick sections, placed
onto super FrostHglass slides (Menzel GmbH & Co KG). Paraffin
sections were deparaffinized and rehydrated with baths of xylene
and graded alcohol. Antigens were unmasked with citrate buffer
(pH = 6) and proteinase K. Sections were treated with peroxidase
for 10 min in order to block endogenous peroxidase activity
followed by 10 min incubation with avidin and biotin. Between
each incubation period, sections were washed in PBS. The
antibodies used were anti-CD3 (1/100, Santa Cruz), anti-CD68
(1/100, (Serotec, Raleigh, NC) and anti-CD31 (1/100, Abcam,
MA). All steps were performed at room temperature. These
samples were analyzed using an Olympus BX50 inverted
microscope. All immunostainings have been confirmed using at
least 5 mice from each group. Negative controls included omission
of primary antibodies or preincubation of primary antibodies with
immunogenic peptides.
Total RNA Extraction and Quantitative Real Time PCR
Total RNA was extracted from renal cortex using TRIzol
reagent (Invitrogen) according to the manufacturer’s instructions.
RNA quality was checked by control of optical density at 260/
280 nm. Contaminating genomic DNA was removed by RNase-
free DNAse (Qiagen) for 15 min at room temperature. cDNA was
synthesized from 1 mg of purified RNA using oligo-dT and
superscript II RT (Qiagen) for 1 h30 at 37uC and 10 min at 70uC.
Real-time PCR amplification was performed with Roche Light
Cycler 480 Sequence Detection System using SYBR Green PCR
Master Mix (Qiagen) as previously described [Huby AC 2009]. All
samples were assayed in triplicate, and the average value of the
triplicate was used for quantification. Results are expressed as the
ratio of a given gene/gene reference (HPRT or 18S) cDNA. All
primers used for the study are listed in Table 1.
Statistical Analyses
Values are expressed as mean6SEM. All data were analyzed
using one-way ANOVA followed by Protected Least Significant
Difference Fisher’s test of the Statview software package. Results
with P,0.05 were considered statistically significant.
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